Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Zeev's Turnips - No Politics -- Ignore unavailable to you. Want to Upgrade?

To: orkrious who wrote (55384)	4/23/2002 11:06:41 PM
From: brightness00	Read Replies (1) \| Respond to of 99280

Truth be told, I think the ultimate price target is ZERO. It's a shell company for PE Biosystems (now Applera) to sell expensive computer systems from the very beginning; i.e. a way to goose up PEB revenue numbers, booking sales instead transfer of equipment inside the company. Government nonrecognition of property rights in the field has long doomed the company's chance for survival. It's like a developer in a country that does not recognize private property rights; what's the chance of that?

To: orkrious who wrote (55384)	4/23/2002 11:44:29 PM
From: Zeev Hed	Read Replies (1) \| Respond to of 99280

Ork, they still have a lot of cash, but frankly, they belong to the category of "new lows beget new lows". Their burn rate is close to $200 plus MM per year and even with $900M in the kitty, unless they start and find a way to generate cash, they may be trash. I also think that the weakness is sector associated and until the bio-pharma sector gets back to the positive trend, they'll drift down. Before you can expect the speculative biotechs to succeed, I think we will need to see the major pharmaceuticals companies to develop basing and new uptrends, I don't see that in the very near future. Take your loss (you probably can cut a buck or two on a short term bounce here in the next day or two) and redeploy, IMTO. Zeev